Johnson & Johnson's HIV vaccine candidate has failed its first major efficacy test, as it was unable to protect women against infection with the virus in a phase 2b trial carried out in sub ...

There were no infections in the young women and girls that got the shots ... HIV. The company said it is waiting for results of testing in men before seeking permission to use it to protect ...

There were no infections in the young women and girls that got the shots ... HIV. The company said it is waiting for results of testing in men before seeking permission to use it to protect ...

The first human clinical trials testing a new strategy to protect against HIV infections have yielded promising early results ...

Vaccines aren’t just for kids. Grown-ups need them to protect against diseases that become ... Who should get it? Young women and some men up to age 26 who didn't get it as preteens or teenagers.

After decades of intense effort, an effective vaccine against HIV is not on ... could be injected to provide many months of protection against HIV infection," Emini says. (The Gates Foundation ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine ...

This annual shot might protect against HIV infections Every year ... a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.

Hopes have been dashed an experimental vaccine could protect people against HIV, the virus that causes Aids. The National Institutes of Health has stopped its HVTN 702 trial, of more than 5,000 ...